Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Peer support is a valuable mode of accompaniment between individuals who are facing or have faced similar challenging life experiences. In this context, a patient advisor (PA) shares their experiential knowledge, derived from living with a disease, to offer emotional, experiential, and informational support to other patients. This PA intervention represents an innovative form of support for oncology patients, potentially addressing their needs more comprehensively throughout the care pathway by integrating psychosocial dimensions into the support approach.
The present pilot study aims to investigate the implementation and effectiveness of the peer-to-peer support program "PaRole OncO France" in the oncology setting. The study will focus on:
Peer support is a valuable mode of accompaniment between individuals who are facing or have faced similar challenging life experiences. In this context, a patient advisor (PA) shares their experiential knowledge, derived from living with a disease, to offer emotional, experiential, and informational support to other patients. This PA intervention represents an innovative form of support for oncology patients, potentially addressing their needs more comprehensively throughout the care pathway by integrating psychosocial dimensions into the support approach.
The present pilot study aims to investigate the implementation and effectiveness of the peer-to-peer support program "PaRole OncO France" in the oncology setting. The study will focus on:
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Supportive care (PaRole OncO France program) | Experimental | Patients participate in the PaRole OncO France program for which they are matched with a patient advisor and followed throughout treatment in person and/or phone. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| PaRole OncO France : Individual peer support | Behavioral | Following the development of the peer support program "PaRole OncO France", we are now proceeding with its implementation and evaluation through a pilot study. This study aims to derive both implementation-related and clinically relevant results. Prior to their assignment, all peer helpers undergo a comprehensive training course to ensure they are well-equipped for their role. Patients receive individual peer support during their treatment visits, providing real-time assistance and support within the clinical setting. The study incorporates three key measurement time points:
At each time points, participants will complete a set of standardized questionnaires. These instruments are designed to capture relevant outcomes and experiences related to the peer support intervention. |
| Measure | Description | Time Frame |
|---|---|---|
| Feasibility of implementation of the Peer Support Program in Oncology | Acceptability of PH intervention by patients, professionals, and PAs Number of PHs integrated per unit Maintenance of PH activity during the study period in each unit Primary outcome measure is multidimensional by design, as the evaluation of a peer support program requires simultaneous analysis of complementary aspects (acceptability, feasibility, fidelity). These elements are inherently interconnected within our methodological framework. | 30 months |
| Measure | Description | Time Frame |
|---|---|---|
| Evolution of stress levels | Hospital Anxiety and Depression Scale (Min: 0; Max: 42). Higher scores indicate levels of anxiety and depression | Baseline |
| Evolution of stress levels | Hospital Anxiety and Depression Scale ((Min : 0; Max : 42).Higher scores indicate greater levels of anxiety and depression. |
Not provided
Inclusion Criteria:
Patient participants :
Patients adivsors :
Exclusion Criteria:
Patients participants :
Patient advisors :
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Juile HASEBAERT, PhD | Contact | 4.72.11.51.65 | +33 | julie.haesebaert01@chu-lyon1.fr |
| Anne TERMOZ | Contact | 04 27 85 63 00 | +33 | anne.termoz@chu-lyon.fr |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospices Civils de Lyon | Lyon | 69495 | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41612477 | Derived | Busnel Y, Pomey MP, Termoz A, Christophe V, Tournigand C, Jouet E, Panse L, Cognon S, Ganter C, Villate A, Maisani P, Preau M, Haesebaert J; Proof investigators group. Implementation and evaluation of a peer-to-peer support program in oncology: study protocol for the PaRole Onco France model. Arch Public Health. 2026 Jan 30;84(1):24. doi: 10.1186/s13690-025-01827-6. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
The intervention consists of patient accompaniment by patient advisors. At least one patient advisor is recruited in each service participating in the study. Patients will be paired with patient advisor and can benefit from accompaniment during their hospital stays or remotely (by phone). The patient advisor will, in turn, be supported by the healthcare professionals' team as well as through a community of practice.
Not provided
Not provided
Not provided
Not provided
|
| 6 months |
| Evolution of quality of life | EORTC QLQ-C30 questionnaire(Min : 0 ; Max : 100).Higher scores indicate better health status and quality of life | Baseline |
| Evolution of quality of life | EORTC QLQ-C30 questionnaire(Min : 0 ; Max : 100).Higher scores indicate better health status and quality of life. | 1 month, 6 month |
| Evolution of patient-perceived care experience | Picker Patient Experience questionnaire(Min : 0 ; Max : 100).Higher scores indicate a better patient experience and greater satisfaction. | Baseline |
| Evolution of patient-perceived care experience | Picker Patient Experience questionnaire(Min : 0 ; Max : 100).Higher scores indicate a better patient experience and greater satisfaction. | 1 month |
| Evolution of patient-perceived care experience | Picker Patient Experience questionnaire(Min : 0 ; Max : 100). Higher scores indicate a better patient experience and greater satisfaction. | 6 months |
| Patient empowerment | CASE-cancer questionnaire(Min :0 ; Max : 100). Higher scores indicate greater self-efficacy in managing cancer. | Baseline |
| Patient empowerment | CASE-cancer questionnaire(Min :0 ; Max : 100). Higher scores indicate greater self-efficacy in managing cancer. | 1 month |
| Patient empowerment | CASE-cancer questionnaire(Min :0 ; Max : 100). Higher scores indicate greater self-efficacy in managing cancer. | 6 month |
| Evolution of relationship between accompanied patients and healthcare professionals | CADICEE questionnaire(Min :0 ; Max : 100). Higher scores indicate a better perception of patient-healthcare partnership | Baseline;1 month and 6 month after intervention |
| Evolution of quality of life of patient advisors | SF-12 questionnaire(Min :0 ; Max : 100)Higher scores indicate better health-related quality of life. | Baseline, 1month, 6 month |
| Hospices Civils de Lyon | Lyon | 69495 | France |
|